Trial intelligence / Profile preview

Optimizing Pharmacist-Led Tobacco Treatment for Smokers Not Ready to Quit

NCT07693660Not yet recruiting

Sponsor
University of Virginia
Start
Dec 2027
Primary completion
Dec 2031
Countries
1
01

Overview

Randomised, open-label trial of nicotine patch in Tobacco Use Disorder (TUD) (16 arms), sponsored by University of Virginia. Primary endpoint: Biochemically confirmed 7-day point prevalence cigarette abstinence at 26 weeks. Planned start Dec 2027; status: not yet recruiting.

02

Drugs

nicotine patch
03

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT07693660.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07693660.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call